Selected research
Industry Growth & Trends
Global CRISPR-Cas9 Gene Editing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global CRISPR-Cas9 Gene Editing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the CRISPR-Cas9 Gene Editing Service market include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global CRISPR-Cas9 Gene Editing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The CRISPR-Cas9 Gene Editing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CRISPR-Cas9 Gene Editing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CRISPR-Cas9 Gene Editing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global CRISPR-Cas9 Gene Editing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
CRISPR-Cas9 Gene Editing Service Market by Company
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizon Discovery Ltd.
EdiGene, Inc.
DetaiBio
CRISPR-Cas9 Gene Editing Service Segment by Type
Knock-in Gene Editing Service
Knock-out Gene Editing Service
Other
CRISPR-Cas9 Gene Editing Service Segment by Application
Cell Line Construction
Animal Models
Bioagriculture
Other
CRISPR-Cas9 Gene Editing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR-Cas9 Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR-Cas9 Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR-Cas9 Gene Editing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CRISPR-Cas9 Gene Editing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Knock-in Gene Editing Service
- Knock-out Gene Editing Service
- Other
Applications
- Cell Line Construction
- Animal Models
- Bioagriculture
- Other
Companies covered
- AMSBIO
- GenScript
- Merck
- Editas Medicine
- Intellia Therapeutics
- CRISPR Therapeutics
- DefiniGEN
- Synthego
- Biocytogen
- Caribou
- Horizon Discovery Ltd.
- EdiGene, Inc.
- DetaiBio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global CRISPR-Cas9 Gene Editing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2021-2032)
- 1.4.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2021-2026)
- 1.4.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Region (2027-2032)
- 1.5 Key Regions CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 1.5.1 North America CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (2021-2032)
2 CRISPR-Cas9 Gene Editing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Knock-in Gene Editing Service
- 2.1.2 Knock-out Gene Editing Service
- 2.1.3 Other
- 2.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Type
- 2.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global CRISPR-Cas9 Gene Editing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global CRISPR-Cas9 Gene Editing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global CRISPR-Cas9 Gene Editing Service Market Size by Regions
- 2.3.1 North America CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Type (2021-2026)
3 CRISPR-Cas9 Gene Editing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Cell Line Construction
- 3.1.2 Animal Models
- 3.1.3 Bioagriculture
- 3.1.4 Other
- 3.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Application
- 3.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global CRISPR-Cas9 Gene Editing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global CRISPR-Cas9 Gene Editing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global CRISPR-Cas9 Gene Editing Service Market Size by Regions
- 3.3.1 North America CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa CRISPR-Cas9 Gene Editing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 CRISPR-Cas9 Gene Editing Service Industry Trends
- 4.2 CRISPR-Cas9 Gene Editing Service Industry Drivers
- 4.3 CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges
- 4.4 CRISPR-Cas9 Gene Editing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by CRISPR-Cas9 Gene Editing Service Revenue (2021-2026)
- 5.2 Global CRISPR-Cas9 Gene Editing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global CRISPR-Cas9 Gene Editing Service Key Company Headquarters & Area Served
- 5.4 Global CRISPR-Cas9 Gene Editing Service Company, Product Type & Application
- 5.5 Global CRISPR-Cas9 Gene Editing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global CRISPR-Cas9 Gene Editing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 CRISPR-Cas9 Gene Editing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 CRISPR-Cas9 Gene Editing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AMSBIO
- 6.1.1 AMSBIO Company Information
- 6.1.2 AMSBIO Business Overview
- 6.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.1.5 AMSBIO Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Editas Medicine
- 6.4.1 Editas Medicine Company Information
- 6.4.2 Editas Medicine Business Overview
- 6.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.4.5 Editas Medicine Recent Developments
- 6.5 Intellia Therapeutics
- 6.5.1 Intellia Therapeutics Company Information
- 6.5.2 Intellia Therapeutics Business Overview
- 6.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.5.5 Intellia Therapeutics Recent Developments
- 6.6 CRISPR Therapeutics
- 6.6.1 CRISPR Therapeutics Company Information
- 6.6.2 CRISPR Therapeutics Business Overview
- 6.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.6.5 CRISPR Therapeutics Recent Developments
- 6.7 DefiniGEN
- 6.7.1 DefiniGEN Company Information
- 6.7.2 DefiniGEN Business Overview
- 6.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.7.5 DefiniGEN Recent Developments
- 6.8 Synthego
- 6.8.1 Synthego Company Information
- 6.8.2 Synthego Business Overview
- 6.8.3 Synthego CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.8.5 Synthego Recent Developments
- 6.9 Biocytogen
- 6.9.1 Biocytogen Company Information
- 6.9.2 Biocytogen Business Overview
- 6.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.9.5 Biocytogen Recent Developments
- 6.10 Caribou
- 6.10.1 Caribou Company Information
- 6.10.2 Caribou Business Overview
- 6.10.3 Caribou CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.10.5 Caribou Recent Developments
- 6.11 Horizon Discovery Ltd.
- 6.11.1 Horizon Discovery Ltd. Company Information
- 6.11.2 Horizon Discovery Ltd. Business Overview
- 6.11.3 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.11.5 Horizon Discovery Ltd. Recent Developments
- 6.12 EdiGene, Inc.
- 6.12.1 EdiGene, Inc. Company Information
- 6.12.2 EdiGene, Inc. Business Overview
- 6.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.12.5 EdiGene, Inc. Recent Developments
- 6.13 DetaiBio
- 6.13.1 DetaiBio Company Information
- 6.13.2 DetaiBio Business Overview
- 6.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.13.5 DetaiBio Recent Developments
7 North America
- 7.1 North America CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 7.3 North America CRISPR-Cas9 Gene Editing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 8.3 Europe CRISPR-Cas9 Gene Editing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 10.3 South America CRISPR-Cas9 Gene Editing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst